New COVID-19 screening technology could test large groups with rapid response

New COVID-19 screening technology could test large groups with rapid response

The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer

NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
US Food and Drug Administration (FDA) grants Breakthrough Therapy Designation to ViiV Healthcare's cabotegravir

ViiV Healthcare’s cabotegravir granted designation for HIV prevention

ViiV Healthcare has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for long-acting, injectable cabotegravir for HIV pre-exposure...
Moderna's COVID-19 vaccine proves 94.5% effective

Moderna’s COVID-19 vaccine proves 94.5% effective

The Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, Moderna’s vaccine candidate against COVID-19, has confirmed that the trial has...
Roche collaborates with Lead Pharma to treat immune mediated diseases

Roche collaborates with Lead Pharma to treat immune mediated diseases

Lead Pharma, a clinical stage pharmaceutical company designing and developing innovative medicines for the treatment of immune mediated diseases and cancer, has entered into...
RDIF and GL Rapha to produce 150 million doses of Sputnik V vaccine per year

RDIF and GL Rapha to produce 150 million doses of Sputnik V vaccine per...

It has been agreed that The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South Korean...
SciBiteAI Relationship Extraction models launched to unlock Life Sciences data

SciBiteAI Relationship Extraction models launched to unlock life sciences data

SciBite has announced the release of its SciBiteAI Relationship Extraction models, which provide the enhanced ability to identify complex relationships within text to further...
Russian Sputnik V vaccine against COVID-19 proves 92% effective

Russian Sputnik V vaccine against COVID-19 proves 92% effective

The National Research Centre for Epidemiology and Microbiology have announced that the Sputnik V vaccine – the world’s first registered vaccine against COVID-19 –...
Industry responds to news about Pfizer’s COVID-19 vaccine

Industry responds to news about Pfizer’s COVID-19 vaccine

With news yesterday that Pfizer Inc and BioNTech SE’s COVID vaccine candidate was found to be more than 90% effective in preventing COVID-19 in...

Latest articles

NHS Prescription Tracker Integration

NHS Prescription Tracker Integration

Cegedim Healthcare Solutions, part of the innovative healthcare technology and service company, Cegedim, has delivered the first-to-market integration of the NHS Prescription Tracker within...
COVID-19 and the counterfeit drug crisis

COVID-19 and the counterfeit drug crisis

The threat posed to the pharmaceutical industry by counterfeit drugs medicines is on the rise - and could be set to get worse unless...
Elsevier report identifies emerging areas of research in pancreatic cancer

Elsevier report identifies emerging areas of research in pancreatic cancer

Elsevier has published the findings of a new report on emerging trends in pancreatic cancer research and literature. The report highlights several trending terms...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
COVID-19 and the counterfeit drug crisis

COVID-19 and the counterfeit drug crisis

The threat posed to the pharmaceutical industry by counterfeit drugs medicines is on the rise - and could be set to get worse unless...
pharmafield logo - pharma news

A Brief History of the NHS

 1948 -NHS establishedThe NHS is born on July 5 1948 out of a long-held ideal that good healthcare should be available to all, regardless...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre

Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre

A collaboration between one of the NIHR’s new National Patient Recruitment Centres (NPRCs) and UK sponsor company Enteromed has led to rapid recruitment to...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription